Lanson BCC SA (ALLAN)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 25.70 |
|---|---|
| 52-week range | 25.60 – 35.40 |
| Return, 1 month / 3 months | −5.5% / −3.4% |
| Return, 1 year / 3 years | −24.7% / −24.7% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 16.5% |
| Worst drawdown (1 year) | -24.2% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lanson BCC is a French wine group based in Reims, in the Champagne region. It owns several champagne houses, including Lanson, Besserat de Bellefon, de Venoge, Philipponnat and Chanoine, and makes and markets champagne and other wines under those labels. Its customers are consumers, restaurants, wine merchants and distributors, and its champagnes are shipped to markets in France and around the world.
Lanson BCC SA trades under the code ALLAN on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lanson BCC SA (ALLAN) trades on the Euronext Paris in France. It last closed at EUR 25.70 on 23 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 259 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.7% and over the last three months it fell 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.7% | ||
| From 52-week high | -26.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.4% | ||
| 6-month return | -0.9% | ||
| 12-month return, skipping the last month | -20.3% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.2% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | −5.5% |
| 3 months | −3.4% |
| 6 months | −0.9% |
| 1 year | −24.7% |
| 3 years | −24.7% |
| 5 years | +1.8% |
Signals
| 50-day / 200-day average | 26.72 / 27.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | EUR 0.6000 |
| 30 Apr 2025 | EUR 0.9000 |
| 2 May 2024 | EUR 1.1000 |
| 17 May 2023 | EUR 1.0000 |
| 2 May 2022 | EUR 0.7000 |
| 30 Apr 2021 | EUR 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.